Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening
Smith A., Moran A., Boyd M., et al. Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening. J Med Genet 44 (2007) 10-15
Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors
Berliner J., and Fay A. Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors. J Genet Couns 16 (2007) 241-260
Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history
Claus E., Schildkraut J., Iversen E., Berry D., and Parmigiani G. Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history. J Natl Cancer Inst 90 (1998) 1824-1829
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes
Antoniou A., Pharoah P., McMullan G., et al. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer 86 (2002) 76-83
Gail MH. Estimation and interpretation of models of absolute risk from epidemiologic data, including family-based studies. Lifetime Data Anal (in press).
8
0030910022
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
Struewing J., Hartge P., Wacholder S., et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336 (1997) 1401-1408
American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography
Saslow D., Boetes C., Burke W., et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57 (2007) 75-89